PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $6,000 | -57.1% | 2,000 | -50.0% | 0.00% | – |
Q1 2016 | $14,000 | +100.0% | 4,000 | +100.0% | 0.00% | – |
Q4 2015 | $7,000 | -30.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2015 | $10,000 | -23.1% | 2,000 | 0.0% | 0.00% | – |
Q2 2015 | $13,000 | -7.1% | 2,000 | 0.0% | 0.00% | – |
Q1 2015 | $14,000 | -6.7% | 2,000 | 0.0% | 0.00% | – |
Q4 2014 | $15,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2014 | $15,000 | -21.1% | 2,000 | 0.0% | 0.00% | – |
Q2 2014 | $19,000 | +11.8% | 2,000 | 0.0% | 0.00% | – |
Q1 2014 | $17,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2013 | $17,000 | +6.2% | 2,000 | 0.0% | 0.00% | – |
Q3 2013 | $16,000 | +6.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2013 | $15,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
Leap Investments LP | 69,496 | $150,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |